The Claim
BPC 157 administration promotes complete healing of intestinal anastomoses and surgical fistulas (gastrocutaneous, duodenocutaneous, colocutaneous) in rat models, even when treatment is delayed by one month.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats with surgical wounds in the gastrointestinal tract, BPC 157 causes complete tissue repair even when given one month after injury.
See the scientific wording
In rat models of intestinal anastomosis and various types of surgical fistulas (gastrocutaneous, duodenocutaneous, colocutaneous), BPC 157 administration promoted complete healing even when treatment was delayed by one month, suggesting a potent and durable effect on tissue repair in the gastrointestinal tract.
BPC 157 increases the availability of nitric oxide in damaged gut tissue, which opens blood vessels and grows new ones, delivering more oxygen and nutrients to the wound. This allows the inner lining of the gut to rebuild its finger-like projections and muscle layers, sealing holes and closing abnormal connections to the skin, even when treatment starts weeks after injury.
What the research says
1 studyStudy: Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
In rats with surgically repaired intestines or abnormal gut-skin openings, giving them BPC 157 even a month after surgery still helped their wounds heal completely — showing it works powerfully and lasts a long time.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.